Genpharm Services has announced today that it is an associate sponsor of the World Orphan Drug Congress USA 2013. The World Orphan Drug Congress is the largest international, commercially-focused event for the advancement of rare disease research and orphan drug development. It gathers regulators, researchers, major companies, field experts, and patient groups to share insights and discuss the latest updates in the field of Orphan Drug development and rare disease research.
The 2013 meeting will be held in Washington DC from 9 to 11 of April. Partners and organizations interested in attending are invited to contact us on firstname.lastname@example.org
Genpharm Services is a company focused on providing market access into the Middle East and North Africa region. Its business is focused on the orphan drugs, rare genetic and auto-immune conditions. Its holistic market approach provides a opportunity for companies with innovative products. It also provides scientific medical support, patient monitoring and follow up. It is managed by senior Pharma and Biotech executives with wide experience in this field and with in depth regional know. It operates with the highest ethical standards.
For more information please visit www.terrapinn.com/Orphan2013Genpharm